Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ATRC

Atricure Inc

Dec 12 • 04:00PM ET

32.79

Dollar change -0.52
Percentage change -1.56	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: BSX ABT MDT EW ISRG BIO JNJ IART LMAT ZBH

| Held by: VTI IWM VB VXF VBK IWO IHI SCHA VTWO IWN

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.83	Insider Own	3.24%	Shs Outstand	48.75M	Perf Week	-3.87%
Market Cap	1.60B	Forward P/E	-	EPS next Y	-0.63	Insider Trans	-0.22%	Shs Float	47.17M	Perf Month	-10.48%
Income	-38.92M	PEG	-	EPS next Q	-0.21	Inst Own	101.62%	Short Float	3.59%	Perf Quarter	16.24%
Sales	447.57M	P/S	3.57	EPS this Y	-23.98%	Inst Trans	-2.67%	Short Ratio	3.14	Perf Half Y	56.37%
Book/sh	9.54	P/B	3.44	EPS next Y	22.56%	ROA	-6.40%	Short Interest	1.69M	Perf Year	-4.12%
Cash/sh	2.67	P/C	12.26	EPS next 5Y	20.00%	ROE	-8.39%	52W Range	18.94 - 39.04	Perf YTD	-8.13%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-1.17%	ROI	-7.21%	52W High	-16.02%	Beta	1.40
Dividend TTM	-	Quick Ratio	2.59	Sales past 5Y	15.61%	Gross Margin	74.12%	52W Low	73.13%	ATR (14)	1.27
Dividend Ex-Date	-	Current Ratio	3.62	EPS Y/Y TTM	-54.97%	Oper. Margin	-7.63%	RSI (14)	39.81	Volatility	3.12% 3.44%
Employees	1200	Debt/Eq	0.17	Sales Y/Y TTM	17.56%	Profit Margin	-8.70%	Recom	1.00	Target Price	45.11
Option/Short	Yes / Yes	LT Debt/Eq	0.16	EPS Q/Q	14.56%	Payout	-	Rel Volume	0.50	Prev Close	33.31
Sales Surprise	3.28%	EPS Surprise	12.78%	Sales Q/Q	17.93%	Earnings	Oct 29 AMC	Avg Volume	539.61K	Price	32.79
SMA20	-6.96%	SMA50	0.34%	SMA200	21.02%	Trades		Volume	270,756	Change	-1.56%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform	$32
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-29-23	Initiated	UBS	Buy	$56
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy	$53 → $63
Nov-06-20	Reiterated	Needham	Buy	$63 → $53
Apr-07-20	Initiated	Oppenheimer	Outperform	$45
Feb-06-20	Initiated	BTIG Research	Buy	$42
Jan-24-20	Reiterated	Needham	Buy	$39 → $48
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform	$30
Apr-12-19	Initiated	JP Morgan	Overweight	$37
Oct-04-18	Reiterated	Needham	Buy	$36 → $39
Aug-02-18	Reiterated	Stifel	Buy	$32 → $34
Aug-02-18	Reiterated	Needham	Buy	$32 → $36
Jun-18-18	Reiterated	Needham	Buy	$26 → $32
Apr-27-18	Reiterated	Needham	Buy	$23 → $26
Jan-16-18	Reiterated	Needham	Buy	$25 → $23
Nov-02-17	Reiterated	Needham	Buy	$26 → $25
Jul-28-17	Reiterated	Needham	Buy	$25 → $26
May-30-17	Resumed	Piper Jaffray	Overweight

Show Previous Ratings

Nov-20-24 08:00AM	AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference (Business Wire)
Nov-07-24 08:00AM	AtriCure to Participate in the Stifel 2024 Healthcare Conference (Business Wire)
Oct-30-24 10:19AM	Q3 2024 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents) +18.35%
03:12AM	AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges (GuruFocus.com)
Oct-29-24 07:00PM	AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:10PM	Loading…
05:10PM	AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:07PM	AtriCure: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-28-24 08:00AM	AtriCure to Participate in the UBS Global Healthcare Conference (Business Wire)
Oct-15-24 08:00AM	AtriCure Announces Launch of cryoSPHERE MAX Probe for Post-Operative Pain Management (Business Wire)
Oct-08-24 08:00AM	AtriCure to Announce Third Quarter 2024 Financial Results (Business Wire)
Oct-01-24 08:00AM	AtriCure Receives CE-Mark for the EnCompass Clamp (Business Wire)
Sep-18-24 10:43AM	Heres Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC) (Insider Monkey)
Aug-28-24 06:32AM	AtriClip FLEX-Mini device treatment begins with first patient (Medical Device Network)
Aug-27-24 08:00AM	AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip FLEX-Mini Device (Business Wire)
12:07PM	Loading…
Aug-23-24 12:07PM	AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication (Zacks)
Aug-22-24 08:00AM	AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices for the Reduction of Stroke in Patients with Atrial Fibrillation (Business Wire)
Jul-30-24 05:30PM	AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:10PM	AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:09PM	AtriCure: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Second Quarter 2024 Financial Results (Business Wire)
Jul-29-24 08:00AM	AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference (Business Wire)
Jul-24-24 10:14AM	AtriCure (ATRC) Gains China Approval for AtriClip LAA System (Zacks)
Jul-23-24 08:00AM	AtriCure Receives Regulatory Approval to Sell AtriClip Devices in China (Business Wire)
Jul-09-24 08:00AM	AtriCure to Announce Second Quarter 2024 Financial Results (Business Wire)
Jun-28-24 06:50AM	Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025 (InvestorPlace)
Jun-21-24 01:44AM	AtriCure (ATRC) Stock Slipped on Competition Threat (Insider Monkey)
May-31-24 07:00PM	Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC) (GuruFocus.com)
May-15-24 08:00AM	AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-02-24 03:18PM	AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript (Insider Monkey) -10.26%
08:36AM	Loading…
08:36AM	Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating (MT Newswires)
03:49AM	AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-01-24 08:57PM	ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:00PM	Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics (Zacks)
05:55PM	AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses (GuruFocus.com)
05:30PM	AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:34PM	AtriCure: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports First Quarter 2024 Financial Results (Business Wire)
Apr-30-24 08:00AM	AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference (Business Wire)
Apr-23-24 07:07AM	--Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32 (MT Newswires)
Apr-19-24 09:45AM	AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management (Zacks)
Apr-18-24 08:00AM	AtriCure Announces Launch of the cryoSPHERE+ Probe for Post-Operative Pain Management (Business Wire)
Apr-10-24 08:00AM	AtriCure to Announce First Quarter 2024 Financial Results (Business Wire) -6.19%
Mar-26-24 08:00AM	AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference (Business Wire)
Mar-22-24 06:40AM	AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug (Insider Monkey)
Mar-07-24 09:01AM	Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC) (GuruFocus.com)
Feb-28-24 12:47AM	AtriCure (ATRC) Fell on Competitor Action (Insider Monkey)
Feb-16-24 11:30AM	AtriCure, Inc. (NASDAQ:ATRC) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:24AM	Q4 2023 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 07:00PM	Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings (Zacks) +5.13%
05:10PM	AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:44PM	AtriCure Inc (ATRC) Reports Strong Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:15PM	AtriCure: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results (Business Wire)
Feb-12-24 09:16AM	Seeking Clues to AtriCure (ATRC) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
Jan-25-24 08:00AM	AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference (Business Wire)
Jan-08-24 08:00AM	AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024 (Business Wire) +6.06%
Jan-04-24 08:00AM	AtriCure Appoints Shlomi Nachman to the Board of Directors (Business Wire)
Dec-20-23 08:00AM	AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (Business Wire)
Nov-15-23 09:55AM	Wall Street Analysts Predict a 36.34% Upside in AtriCure (ATRC): Here's What You Should Know (Zacks)
08:00AM	AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-14-23 08:00AM	AtriCure Releases 2023 ESG Report (Business Wire) +10.11%
Nov-06-23 12:00PM	All You Need to Know About AtriCure (ATRC) Rating Upgrade to Buy (Zacks)
Nov-02-23 03:14PM	AtriCure, Inc. (NASDAQ:ATRC) Q3 2023 Earnings Call Transcript (Insider Monkey)
09:23AM	Q3 2023 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 06:22PM	AtriCure Inc (ATRC) Reports Q3 2023 Earnings: 18.1% YoY Revenue Growth (GuruFocus.com)
06:00PM	AtriCure (ATRC) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
04:19PM	AtriCure: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	AtriCure Reports Third Quarter 2023 Financial Results (Business Wire)
Oct-31-23 08:00AM	AtriCure to Participate in the Stifel 2023 Healthcare Conference (Business Wire)
Oct-11-23 08:00AM	AtriCure to Announce Third Quarter 2023 Financial Results (Business Wire) -5.28%
Sep-29-23 09:40AM	Brinker upgraded, Berkshire Hathaway downgraded: Wall Street's top analyst calls (The Fly)
Sep-11-23 11:45AM	Unveiling AtriCure (ATRC)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-09-23 07:32PM	Unveiling AtriCure (ATRC)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Jul-29-23 01:10AM	Insider Sell: AtriCure Inc's Chief Legal Officer Karl Dahlquist Sells 3,417 Shares (GuruFocus.com)
Jul-27-23 08:50AM	AtriCure, Inc.'s (NASDAQ:ATRC) Intrinsic Value Is Potentially 63% Above Its Share Price (Simply Wall St.) -5.18%
Jul-26-23 07:49AM	Q2 2023 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents) +8.54%
Jul-25-23 08:00PM	AtriCure (ATRC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	AtriCure (ATRC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:11PM	AtriCure: Q2 Earnings Snapshot (AP Finance)
04:01PM	AtriCure Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-21-23 08:00AM	AtriCure to Participate at Upcoming Investor Conferences (Business Wire)
Jul-03-23 08:00AM	AtriCure to Announce Second Quarter 2023 Financial Results (Business Wire)
May-25-23 04:02AM	UPDATE 1-Abu Dhabi makes its Falcon 40B AI model open source (Reuters)
May-04-23 06:21AM	AtriCure First Quarter 2023 Earnings: Beats Expectations (Simply Wall St.)
May-03-23 10:50AM	Q1 2023 AtriCure Inc Earnings Call (Thomson Reuters StreetEvents) +9.99%
May-02-23 05:25PM	AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:21PM	AtriCure: Q1 Earnings Snapshot (AP Finance)
04:01PM	AtriCure Reports First Quarter 2023 Financial Results (Business Wire)
Apr-19-23 08:00AM	AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast (Business Wire)
Apr-17-23 10:42AM	AtriCure, Inc.'s (NASDAQ:ATRC) Popularity With Investors Is Clear (Simply Wall St.)
Apr-11-23 08:00AM	AtriCure to Announce First Quarter 2023 Financial Results (Business Wire)
Apr-03-23 08:00AM	AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference (Business Wire)
Apr-01-23 09:41PM	Atreca, Inc. (NASDAQ:BCEL) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-27-23 08:29AM	AtriCure (ATRC) Moves 7.5% Higher: Will This Strength Last? (Zacks)
Mar-18-23 09:14AM	AtriCure (NASDAQ:ATRC) lifts 9.3% this week, taking five-year gains to 96% (Simply Wall St.)
Feb-25-23 02:14PM	12 Most Promising Medical Stocks According to Analysts (Insider Monkey)
Feb-21-23 05:15PM	AtriCure (ATRC) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +8.26%
04:14PM	AtriCure: Q4 Earnings Snapshot (AP Finance)
04:00PM	AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results (Business Wire)

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yuen Maggie	Director	Aug 15 '24	Sale	24.07	3,500	84,245	8,970	Aug 19 08:46 AM
Yuen Maggie	Director	Aug 15 '24	Proposed Sale	24.07	3,500	84,245		Aug 15 08:06 PM
Privitera Salvatore	Chief Technical Officer	May 30 '24	Buy	22.25	5,000	111,250	103,290	May 31 04:12 PM
Noznesky Justin J	Chief Mktg & Strategy Officer	May 01 '24	Sale	24.09	1,500	36,135	71,284	May 03 08:51 AM
Noznesky Justin J	Chief Mktg & Strategy Officer	Apr 01 '24	Sale	30.39	1,500	45,585	72,784	Apr 03 08:41 AM
Dahlquist Karl S.	Chief Legal Officer	Mar 18 '24	Sale	32.16	1,885	60,622	50,954	Mar 20 08:41 AM
Noznesky Justin J	Chief Mktg & Strategy Officer	Mar 12 '24	Sale	36.72	1,500	55,080	74,284	Mar 14 08:55 AM
Dahlquist Karl S.	Chief Legal Officer	Mar 05 '24	Sale	37.36	8,231	307,510	52,839	Mar 07 07:28 AM
Wirick Angela L	Chief Financial Officer	Mar 01 '24	Option Exercise	16.95	5,000	84,750	139,070	Mar 05 04:46 PM
WHITE ROBERT S.	Director	Feb 23 '24	Option Exercise	15.96	10,000	159,600	88,985	Feb 27 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ATRC

Atricure Inc

Upgrade your FINVIZ experience